TWIST BIOSCIENCE CORP

Profile

Company Names

TWIST BIOSCIENCE CORP

Addresses

455 MISSION BAY BLVD. SOUTH, SUITE 545, SAN FRANCISCO, CA 94158

455 MISSION BAY BOULEVARD SOUTH, SUITE 5, SAN FRANCISCO, CA 94158

455 MISSION BAY BOULEVARD SOUTH, SUITE 545, SAN FRANCISCO, CA 94158

974 RHODE ISLAND STREET, SAN FRANCISCO, CA 94107

Phone Numbers

408-410-0105

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$260,758,121.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2018-03-19 
$50,000,000.00 
$85,000,000.00 
$35,000,000.00 
Equity 
6
2017-03-09 
$74,949,996.00 
$75,000,000.00 
$50,004.00 
Equity 
5
2016-04-05 
$2,650,000.00 
$2,650,000.00 
$0.00 
Equity 
4
2016-01-08 
$61,047,413.00 
$61,047,413.00 
$0.00 
Equity 
3
2015-05-29 
$36,999,999.00 
$36,999,999.00 
$0.00 
Equity 
2
2014-05-13 
$25,999,999.00 
$26,500,001.00 
$500,002.00 
Equity 
1
2013-07-01 
$9,110,714.00 
$9,298,571.00 
$187,857.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
 
BANYAI 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
CHARLES 
BANYAI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ROB 
 
CHESS 
DIRECTOR
FRED 
 
CRAVES 
DIRECTOR
SOLANGE 
 
GLAIZE 
EXECUTIVE OFFICER
EMILY 
MARINE 
LEPROUST 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
MINQI 
 
LI 
DIRECTOR
NICK 
 
NACLERIO 
DIRECTOR
BILL 
 
PECK 
EXECUTIVE OFFICER
BILL 
JAMES 
PECK 
EXECUTIVE OFFICER, PROMOTER
BOB 
 
RAGUSA 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-03-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-13 
D/A
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-01 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#